Cargando…
Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma
Glioma is one of the most aggressive and common malignant brain tumors. Due to the presence of the blood-brain barrier (BBB), the effectiveness of therapeutics is greatly affected. In this work, to develop an efficient anti-glioma drug with targeting and which was able to cross the BBB, cell-penetra...
Autores principales: | Wang, Xi, Zhao, Yarong, Dong, Shiyan, Lee, Robert J., Yang, Dongsheng, Zhang, Huan, Teng, Lesheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804123/ https://www.ncbi.nlm.nih.gov/pubmed/31574945 http://dx.doi.org/10.3390/molecules24193540 |
Ejemplares similares
-
Correction: Wang et al. Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma. Molecules 2019, 24, 3540
por: Wang, Xi, et al.
Publicado: (2022) -
A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy
por: QIN, LI, et al.
Publicado: (2014) -
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application
por: Xie, Jing, et al.
Publicado: (2020) -
A Novel Isoquinoline Derivative Anticancer Agent and Its Targeted Delivery to Tumor Cells Using Transferrin-Conjugated Liposomes
por: Yang, Xuewei, et al.
Publicado: (2015) -
Transferrin-conjugated liposomes loaded with novel dihydroquinoline derivatives as potential anticancer agents
por: Wang, Mengqiao, et al.
Publicado: (2017)